MRDWI联合CEA及SCC在子宫颈鳞癌同步放化疗疗效评估中的应用研究

doi:10.3760/cma.j.issn.1004-4221.2017.09.009

Abstract
Figure/Table
References()
Related Citation (15)
Read Tracking
Download Tracking

Download: PDF (883 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Abstract Objective To determine the value of the apparent diffusion coefficient (ADC) of magnetic resonance diffusion-weighted imaging (MRDWI) combined with squamous cell carcinoma antigen (SCC) and carcinoembryonic antigen (CEA) in the evaluation of the efficacy and prognosis of concurrent chemoradiotherapy for cervical carcinoma. Methods A total of 80 patients with cervical squamous cell carcinoma confirmed by histology or cytology in our hospital from 2013 to 2016 were included in this study. Of the 80 patients, 39 were FIGO stage Ⅱ_B, 7 were stage Ⅲ_A, 26 were stage Ⅲ_B, and 8 were stage ⅠVA. MRDWI examination and SCC and CEA measurements were first performed for the patients following group assignment, and the patients were then given extrapelvic radiotherapy (45-50 Gy)+platinum-based chemotherapy plus brachytherapy (20-25 Gy) based on their conditions. MRDWI, SCC, and CEA examinations were performed again after treatment to determine the changes in ADC, SCC, and CEA. In addition, ADC, SCC, and CEA were examined in the middle stage of treatment for 40 patients. Data were analyzed using the paired t-test or ANOVA. Results The overall response rate of the 80 patients after concurrent chemoradiotherapy was 100%. No disease progression was identified in any of the patients until the end of treatment, and the overall survival time of the patients was all above 6 months. Serum SCC and CEA were reduced after treatment (P=0.000,0.000), whereas the ADC value was increased after treatment (P=0.000). The increase in ACD following the decreases in SCC and CEA after treatment (P=0.000, 0.000) was indicative of increased efficacy of the concurrent chemotherapy and radiotherapy. Conclusions MRDWI combined with SCC and CEA is highly reliable for the evaluation of efficacy and prognosis of concurrent chemoradiotherapy for cervical cancer.

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Jiang Xin
	Zhu Wei
	Yu Dedong
	Wu Yun

Key words： Cervical neoplasms Magnetic resonance diffusion-weighted imaging Tumor marker Concurrent chemoradiotherapy

Received: 04 January 2017

Corresponding Authors: Wu Yun,Email:1203119865@qq.com

Cite this article:

Jiang Xin,Zhu Wei,Yu Dedong et al. Application of MRDWI combined with CEA and SCC in evaluation of the efficacy of concurrent chemoradiotherapy for cervical squamous cell carcinoma[J]. Chinese Journal of Radiation Oncology, 2017, 26(9): 1024-1027.

URL:

http://journal12.magtechjournal.com/Jweb_fszlx/EN/10.3760/cma.j.issn.1004-4221.2017.09.009 OR http://journal12.magtechjournal.com/Jweb_fszlx/EN/Y2017/V26/I9/1024

[1] 张燕茹,王月云,刘植华. 宫颈癌防治研究进展[J]. 中国肿瘤,2015,(12):998-1002.
Zhang YR,Wang YY,Liu ZH.Research progress in prevention and control of cervical cancer[J].China Cancer,2015,24(12):998-1002.DOI:10.11735/j.issn.1004-0242.2015.12.A008.
[2] 胡尚英,郑荣寿,赵方辉,张思维,陈万青,乔友林. 1989至2008年中国女性子宫颈癌发病和死亡趋势分析[J]. 中国医学科学院学报,2014,(02):119-125.
Hu SY,Zheng RS,Zhao FH,el al. Trend analysis of cervical cancer incidence and mortality rates in Chinese women during 1989-2008[J].Acta Acad Med Sin,2014,36(2):119-125.DOI:10.3881/j.issn.1000-503X.2014.02.001.
[3] 赵艺,郝淑维,崔澂. 宫颈癌的个体化综合化治疗进展[J]. 医学综述,21017,(0):76-81.
Zhao Y,Hao SW,Cui C.The Progress in individualized treatment of cervical cancer[J].Med Sum,2017,(1):76-81.
[4] Gaffney DK,Jhingran A,Portelance L,et al. Radiation therapy oncology group gynecologic oncology working group:comprehensive results[J].Int J Gynecol Cancer,2014,24(5):956-962.DOI:10.1097/IGC.0000000000000135.
[5] 宝莹娜,郁志龙,黄丛秀,等.宫颈癌患者血清SCC CEA表达水平的变化及其临床意义[J].河北医学,2016,22(10):1670-1672.DOI:10.3969/j.issn.1006-6233.2016.10.035.
Huang CX,Bao YN,Yu ZL,et al. Changes of serum SCC and CEA levels in patients with cervical cancer and their clinical significance[J].Hebei Med,2016,22(10):1670-1672.DOI:10.3969/j.issn.1006-6233.2016.10.035.
[6] 徐永立,段小丽,潘剑岩,等.宫颈癌诊断中动态增强MRI半定量参数与磁共振扩散加权成像ADC值的相关性研究[J].检验医学与临床,2016,13(22):3180-3182,3185.DOI:10.3969/j.issn.1672-9455.2016.22.019.
Xu YL,Duan XL,Pan JY,et al. Correlation between MRI semi quantitative parameters and ADC values of diffusion weighted imaging in diagnosis of cervical cancer[J].Lab Med Clin,2016,13(22):3180-3182,3185.DOI:10.3969/j.issn.1672-9455.2016.22.019.
[7] 鲁文力,李英,黄维,等.扩散加权成像表观扩散系数预测和评估宫颈癌同步放化疗疗效[J].中国医学物理学杂志,2016,33(10):997-1001.DOI:10.3969/j.issn.1005-202X.2016.10.005.
Lu WL,Li Y,Huang W,et al. Apparent diffusion coefficient of diffusion weighted imaging in predicting and assessing chemoradiotherapy effect of cervical carcinoma[J].Chin J Med Phys,2016,33(10):997-1001.DOI:10.3969/j.issn.1005-202X.2016.10.005.
[8] vargas HA,Akin O,Zheng JT,et al. The value of MR imaging when the site of uterine cancer origin is uncertain[J].Radiology,2011,258(3):785-792.DOI:10.1148/radiol.10101147.
[9] Vincens E,Balleyguier C,Rey A,et al. Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage ⅠB2/Ⅱ cervical carcinoma with chemoradiation therapy:correlation of radiologic findings with surgicopathologic results[J].Cancer,2008,113(8):2158-2165.DOI:10.1002/cncr.23817.
[10] 涂彬彬,吴令英,黄曼妮,等.中晚期子宫颈鳞癌同步放化疗的疗效及预后因素分析[J].中华妇产科杂志 2014,49(5):348-354.DOI:10.3760/cma.j.issn.0529-567x.2014.05.006.
Tu BB,Wu LY,Huang MN,et al. Outcomes and prognostic factors of advanced squamous cervical cancer after concurrent chemoradiotherapy[J].Chin J Obstetr Gynecol,2014,49(5):348-354.DOI:10.3760/cma.j.issn.0529-567x.2014.05.006.
[11] 李璐,王留兴,许国林,等.血清SccAg、CA₁₂₅、CA19-9的联合检测对宫颈癌的诊断价值[J].中外医疗,2016,35(14):75-78.DOI:10.16662/j.cnki.1674-0742.2016.14.075.
Li L,Wang LX,Xu GL,et al. Diagnostic value of the combined detection of serum SccAg,CA₁₂₅ and CA19-9 for cervical carcinoma[J].China Foreign Med Treat,2016,35(14):75-78.DOI:10.16662/j.cnki.1674-0742.2016.14.075.
[12] 程金龙,徐冶,谢宏宇,等.宫颈癌新辅助化疗前后SCC-Ag水平与化疗敏感性的关系[J].现代肿瘤医学,2016,24(23):3790-3793.DOI:10.3969/j.issn.1672-4992.2016.23.029.
Cheng JL,Xu Y,Xie HY,et al. The relationship between SCC-Ag level and chemotherapy sensitivity in cervical cancer before and after neoadjuvant chemotherapy[J].J Mod Oncol,2016,24(23):3790-3793.DOI:10.3969/j.issn.1672-4992.2016.23.029.
[13] 梁指荣,杨洁飞,苏锡康.多种肿瘤标记物检测在宫颈癌诊治中的意义[J].国际检验医学杂志,2016,37(1):21-23.DOI:10.3969/j.issn.1673-4130.2016.01.009.
Liang ZR,Yang JF,Su XK.Significance of various tumor markers detection in diagnosis and treatment of cervical cancer[J].Int J Lab Med,2016,37(1):21-23.DOI:10.3969/j.issn.1673-4130.2016.01.009.
[14] 闫慧,薛冰.血清肿瘤标志物CA₁₂₅、CEA联合检测在宫颈癌诊断中的临床价值[J].国际检验医学杂志,2016,37(1):134-135.DOI:10.3969/j.issn.1673-4130.2016.01.066.
Yan H,Xue B.The clinical value of combined detection of serum tumor markers CA₁₂₅ and CEA in the diagnosis of cervical cancer[J].Int J Lab Med,2016,37(1):134-135.DOI:10.3969/j.issn.1673-4130.2016.01.066.